UPDATE : Wednesday, January 23, 2019
Court rejects patent registration for acute myeloid leukemia drug Vyxeos by Lee Hye-seon 2019-01-23 14:47
Lilly returns rights for Hanmi’s BTK inhibitor candidate by Lee Han-soo 2019-01-23 10:21
Bridge Biotherapeutics licenses in new immunotherapy candidate by Lee Han-soo 2019-01-23 10:20
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment by Lee Han-soo 2019-01-22 16:03
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’ by Park Gi-taek 2019-01-22 14:18
BMS, Ono Pharma wins more indication for Opdivo in EU by Lee Han-soo 2019-01-21 18:01
New HIV combo pill Biktarvy approved in Korea by Lee Hye-seon 2019-01-21 15:36
JW wins sales go-ahead for hemophilia A treatment by Lee Han-soo 2019-01-21 15:35
Novo Nordisk increases market share for mixed insulin in Korea by Lee Han-soo 2019-01-21 14:44
Sillajen releases interim results for combination cancer treatment in US by Lee Han-soo 2019-01-21 14:20
OliX unveils new drug candidate for treating geographic atrophy by Lee Han-soo 2019-01-18 15:17
‘Pharmaceuticals need President Moon’s committed support’ by Lee Hye-seon 2019-01-17 17:39
Daewoong to use cloud service for safe drug management by Lee Han-soo 2019-01-17 15:37
EN Cell to make Hanmi’s anti-cancer gene stem cell therapy by Lee Han-soo 2019-01-17 12:34
‘Tagrisso’s benefit as 1st-line treatment overrides resistance risk’ by Park Gi-taek 2019-01-17 12:34
Bridge Biotherapeutics’ idiopathic pulmonary fibrosis treatment wins orphan drug status by Lee Han-soo 2019-01-17 11:04
Daewoong, Yonsei University to develop customized diagnosis, treatment system for cancer patients by Lee Han-soo 2019-01-16 17:19
Genexine, NeoImmuneTech wins FDA nod for clinical trials of GX-I7 by Lee Han-soo 2019-01-16 16:12
MSD gains additional indication for Keytruda by Lee Han-soo 2019-01-16 14:01
NK Max submits plans for P1 clinical trial for immunotherapy in US by Lee Han-soo 2019-01-16 11:36
Back to Top